|
Volumn 3, Issue 2, 2014, Pages 123-136
|
Molecular and genetic pathways in gliomas: the future of personalized therapeutics
|
Author keywords
1p 19q; anaplastic glioma; Avastin; BRAF inhibitors; convection based therapy; cyclin inhibitors; EGRF; EGRFvIII; glioblastoma; glioma; glioma vaccines; oligodendroglioma; p53; PCV; personalized medicine; temozolamide
|
Indexed keywords
TUMOR MARKER;
ANIMAL;
BRAIN NEOPLASMS;
CLASSIFICATION;
GENETICS;
GLIOMA;
HUMAN;
METABOLISM;
PERSONALIZED MEDICINE;
PROCEDURES;
ANIMALS;
BRAIN NEOPLASMS;
GLIOMA;
HUMANS;
INDIVIDUALIZED MEDICINE;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84920794698
PISSN: None
EISSN: 20450915
Source Type: Journal
DOI: 10.2217/cns.14.7 Document Type: Review |
Times cited : (23)
|
References (0)
|